Printer Friendly
The Free Library
19,585,763 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biovail to Present at the JPMorgan Annual High Yield Conference 2007.


TORONTO -- Biovail Corporation (NYSE NYSE

See: New York Stock Exchange
:BVF BVF Biovail Corporation (stock symbol)
BVF Berufsverband der Frauenärzte eV (Muenchen, Germany)
BVF Bearing Versus Frequency
)(TSX TSX Toronto Stock Exchange (TSE before April, 2002)
TSX Transfer from Stack Pointer to Index
TSX True Space Extension
:BVF) today announced that the Company will present at the JPMorgan Annual High Yield Conference 2007 at the Loews Miami Beach Hotel in Miami, Florida.

Biovail's presentation is scheduled for Tuesday, January 23, 2007 at 1.30 p.m. EST. JPMorgan will not Webcast this conference; however, the presentation slides will be available on the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 page of Biovail's Web site at www.biovail.com.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the company's Web site at www.biovail.com.

For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 19, 2007
Words:130
Previous Article:The Law Firm of Goldman Scarlato & Karon, P.C. Announces Class Action Lawsuit Against Hornbeck Offshore Services, Inc.
Next Article:Research and Markets: Dr. August Oetker 2006 Company Profile Is Ideal For Busy Executives Who Just Need The Key Facts Now!
Topics:



Related Articles
Biovail Prices US$400 Million 7.875% Senior Subordinated Notes Due 2010.
Biovail to Present at 22nd JP Morgan Healthcare Conference.
Biovail to Present at 24th Annual JPMorgan Healthcare Conference.
Biovail to Present at the JPMorgan Annual High Yield Conference 2006.
Biovail to Present at Upcoming Conferences.
Biovail to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference.
Biovail to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference.
Biovail to Present at the Scotia Capital Spring Growth Conference.
Biovail to Present at the Morgan Stanley Global Healthcare Unplugged Conference.
Biovail to Present at Citigroup 2007 Healthcare Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles